Question follow-through · 65234

Faculty: Medical Records

To ask the Secretary of State for Health and Social Care, whether Faculty will have access to NHS patient DNA data through Government contracts.

answeredDepartment of Health and Social Care

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body
Department of Health and Social Care
Tabled
7 Jul 2025
Target answer date
10 Jul 2025
Answer
14 Jul 2025 · 7 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

More questions by this MP on Health and care

Shared topic keywords suggest a connection; they do not establish a follow-up.

Votes on this topic

These Commons divisions share a topic label. The question did not necessarily lead to a vote.

Recorded timeline

  1. 7 Jul 2025

    Question tabled

    To ask the Secretary of State for Health and Social Care, whether Faculty will have access to NHS patient DNA data through Government contracts.

  2. 10 Jul 2025

    Target answer date

    Date supplied by the official written-questions record.

  3. 14 Jul 2025

    Answer published

    No data relating to patients’ DNA is included in the datasets processed in the NHS Federated Data Platform provided by a consortium led by Palantir. Faculty had no access to patient DNA data as part of any contract with the Department of Health and Social...

Open official record

Official data retrieved 28 Sept 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Tuberculosis: Drugs and Medical Treatments

14 Nov 2025 · To ask the Secretary of State for Health and Social Care, what steps he is taking to (a) address shortages in tuberculosis (TB) medications, including drugs for preventive and active TB treatment and (b) ensure that patients are not put at risk due to dis